AI-designed viruses used to treat a human patient for the first time, targeting drug-resistant E. coli
Polymarket · x · 2026-10-20
A biotech startup says it has treated a human patient with AI-designed viruses for the first time, targeting an antibiotic-resistant E. coli infection — a landmark step for AI-designed therapeutics moving from the lab into clinical use.
More from Apps
- OpenAI Launches ChatGPT Team Tasks for Automating Recurring Engineering Work — OpenAIDevs · 2026-10-20
- LukeW Details His Personal AI Pipeline: Hourly Auto-Indexing of Audio, Video and PDFs — LukeW · 2026-10-20
- Anam launches Cara-4.1 Express: 1.2s latency digital human beats HeyGen for 85% of blind raters — Div_pradeep · 2026-10-20
- Gakku's AI tutor Raku teaches kids storytelling skills instead of writing for them — HeyAmit_ · 2026-10-20
- He has free lifetime GPT Pro but pays for Claude Code: a full daily AI stack — tyler_agg · 2026-10-20
- Addys AI review: cuts post-meeting work from 20 minutes to 3, no bot joins calls — tom_tt2 · 2026-10-20